Corrigendum to 'A phase II trial of paclitaxel plus biweekly cetuximab for patients with recurrent or metastatic head and neck cancer previously treated with both platinum-based chemotherapy and anti-PD-1 antibody': [ESMO Open volume 9 issue 6 (2024) 103476].
ESMO Open
; 9(8): 103652, 2024 Aug.
Article
em En
| MEDLINE
| ID: mdl-39033684
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Idioma:
En
Revista:
ESMO Open
Ano de publicação:
2024
Tipo de documento:
Article